OBJECTIVE: We evaluated vaginal defensin concentrations and levels of bacterial vaginosis-associated bacterial species in pregnant women. STUDY DESIGN: Self-collected vaginal swabs from 2 visits during pregnancy were tested with quantitative polymerase chain reaction for 9 bacterial species. Beta defensins 2-3 and alpha defensins 1-3 were measured by enzyme-linked immunosorbent assay. RESULTS: Our 126 participants were primarily African American (60%), had a mean gestational age at enrollment of 10 ± 3 weeks and at follow-up visit of 25 ± 6 weeks. At enrollment, the prevalence of bacterial vaginosis was 74% (94/126 women), which decreased to 60% (75/126 specimens) at follow-up visit. At enrollment, beta defensin 3 concentrations were significantly lower in women with bacterial vaginosis (2.64 ± 0.91 vs 3.25 ± 0.99 log(10) pg/mL; P = .003). Higher concentrations of Atopobium vaginae, bacterial vaginosis-associated bacteria1 and 2 were associated with significantly lower concentrations of beta defensin 3 (P < .01). CONCLUSION: Bacterial vaginosis was associated with lower vaginal concentrations of beta defensin 3, but not beta defensin 2 or alpha defensins 1-3, in pregnant women.
OBJECTIVE: We evaluated vaginal defensin concentrations and levels of bacterial vaginosis-associated bacterial species in pregnant women. STUDY DESIGN: Self-collected vaginal swabs from 2 visits during pregnancy were tested with quantitative polymerase chain reaction for 9 bacterial species. Beta defensins 2-3 and alpha defensins 1-3 were measured by enzyme-linked immunosorbent assay. RESULTS: Our 126 participants were primarily African American (60%), had a mean gestational age at enrollment of 10 ± 3 weeks and at follow-up visit of 25 ± 6 weeks. At enrollment, the prevalence of bacterial vaginosis was 74% (94/126 women), which decreased to 60% (75/126 specimens) at follow-up visit. At enrollment, beta defensin 3 concentrations were significantly lower in women with bacterial vaginosis (2.64 ± 0.91 vs 3.25 ± 0.99 log(10) pg/mL; P = .003). Higher concentrations of Atopobium vaginae, bacterial vaginosis-associated bacteria1 and 2 were associated with significantly lower concentrations of beta defensin 3 (P < .01). CONCLUSION:Bacterial vaginosis was associated with lower vaginal concentrations of beta defensin 3, but not beta defensin 2 or alpha defensins 1-3, in pregnant women.
Authors: Deborah B Nelson; Scarlett Bellamy; Bonnie A Clothier; George A Macones; Irving Nachamkin; Althea Ruffin; Lynne Allen-Taylor; Frank K Friedenberg Journal: Matern Child Health J Date: 2007-06-02
Authors: David N Fredricks; Tina L Fiedler; Katherine K Thomas; Caroline M Mitchell; Jeanne M Marrazzo Journal: J Clin Microbiol Date: 2009-01-14 Impact factor: 5.948
Authors: Deborah B Nelson; Alexandra Hanlon; Sarmina Hassan; Johnson Britto; Osnat Geifman-Holtzman; Catherine Haggerty; David N Fredricks Journal: J Perinat Med Date: 2009 Impact factor: 1.901
Authors: G G Donders; K Van Calsteren; G Bellen; R Reybrouck; T Van den Bosch; I Riphagen; S Van Lierde Journal: BJOG Date: 2009-06-17 Impact factor: 6.531
Authors: Pauline Levinson; Rupert Kaul; Joshua Kimani; Elizabeth Ngugi; Stephen Moses; Kelly S MacDonald; Kristina Broliden; Taha Hirbod Journal: AIDS Date: 2009-01-28 Impact factor: 4.177
Authors: Violetta Florova; Roberto Romero; Adi L Tarca; Jose Galaz; Kenichiro Motomura; Madison M Ahmad; Chaur-Dong Hsu; Richard Hsu; Anna Tong; Jacques Ravel; Kevin R Theis; Nardhy Gomez-Lopez Journal: Cytokine Date: 2020-10-07 Impact factor: 3.861
Authors: Ehab H Mattar; Hussein A Almehdar; Abdullah A AlJaddawi; Isam ElDin M Abu Zeid; Elrashdy M Redwan Journal: J Immunol Res Date: 2016-06-20 Impact factor: 4.818
Authors: Michal A Elovitz; Pawel Gajer; Valerie Riis; Amy G Brown; Michael S Humphrys; Johanna B Holm; Jacques Ravel Journal: Nat Commun Date: 2019-03-21 Impact factor: 14.919
Authors: Lorraine Frew; Sofia Makieva; Andrew T M McKinlay; Brian J McHugh; Ann Doust; Jane E Norman; Donald J Davidson; Sarah J Stock Journal: PLoS One Date: 2014-08-04 Impact factor: 3.240
Authors: Aastha Khatiwada; Bethany J Wolf; Jennifer K Mulligan; Judy R Shary; Martin Hewison; John E Baatz; Danforth A Newton; Catherine Hawrylowicz; Bruce W Hollis; Carol L Wagner Journal: Pediatr Res Date: 2020-04-20 Impact factor: 3.756